Factor V Leiden and apolipoprotein E genotypes in severe femoropopliteal atherosclerosis with restenosis

Clinica Chimica Acta

Volumn 377, Issue 1-2, 2007, Pages 256-260

  Vallus, Gábor ^a   Dlustus, Béla ^a   Acsády, György ^c   Papp, Zoltán ^c   Skopál, Judit ^b   Nagy, Zoltán ^b   Prohászka, Zoltán ^d   Romics, László ^d   Karádi, István ^d   Nagy, Bálint ^c  

^a Central Military Hospital Budapest   (Hungary)

^b National Stroke Center   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Apolipoprotein E genotype; Arteficial graft; Factor V (Leiden); Femoropopliteal atherosclerosis and restenosis; Lipoprotein

Indexed keywords

APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; ENDONUCLEASE; LIPOPROTEIN;

ADULT; AGED; ALLELE; ANGIOPLASTY; ANTICOAGULATION; ARTICLE; ATHEROSCLEROSIS; BLOOD DONOR; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESTENOSIS; REVASCULARIZATION; STATISTICAL SIGNIFICANCE; THROMBOPHILIA;

ADULT; AGED; ALLELES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CONSTRICTION, PATHOLOGIC; DISEASE PROGRESSION; FACTOR V; FEMALE; FEMUR; GENOTYPE; HEALTH; HUMANS; MALE; MIDDLE AGED; MUTATION; RISK FACTORS;

EID: 33845522688     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.10.004     Document Type: Article

References (27)

1. Isner J.M. Mechanisms of restenosis after lower extremity angioplasty. J Vasc Surg 22 (1995) 114-115
2. Faxon D.P. Identifying the predictors of restenosis. Do we need new glasses?. Circulation 95 (1997) 2244-2246
3. Bertina R.M., Koeleman P.C., Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
4. Rosendaal F.R., Koster T., Vandenboucke J.P., and Reitsma P.H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85 (1995) 1504-1508
5. Walker R.N., Bowen-Pope D.F., Ross R., et al. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A 83 (1986) 7311-7315
6. Bachhuber B.G., Sarembock I.J., Mcnamara C.J., et al. Thrombin induced proliferation of cultured vascular smooth muscle cells requires prolonged exposure to thrombin. Circulation 88 Suppl I (1993) 468A
7. Inoue T., Sakai Y., Fujito T., et al. Clinical significance of neutrophil adhesion molecules expression after coronary angioplasty on the development of restenosis. Thromb Haemost 79 (1998) 54-58
8. Tiret L., et al., for the EARS study group. ApoE polymorphism and predisposition to coronary heart disease in youth of different European populations. The EARS Study. Arterioscler Thromb 4 (1994) 1617-1624
9. Wang X.L., McCredie R.M., and Wilcken D.E. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vasc Biol 5 (1995) 030-034
10. Cattin L., Fisicaro M., Tonizzo M., et al. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. Arterioscler Thromb Vasc Biol 7 (1997) 9-94
11. Vogel T., Guo N.H., Guy R., et al. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem 54 (1994) 299-308
12. O'Brien K.D., Deeb S.S., Ferguson M., et al. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol 44 (1994) 535-548
13. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
14. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31 (1990) 545-548
15. Ridker P.M., Hennekens C.H., Lindpaintner K., Stampfer M.J., Eisenberg P.R., and Miletich J.P. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332 (1995) 92-97
16. Rosendaal F.R., Siscovick D.S., Schwartz S.M., et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 89 (1997) 2817-2821
17. Eritsland J., Gjonnes G., Sandset P.M., Seljefot I., and Arnesen H. Activated protein C resistance and graft occlusion after coronary bypass surgery. Thromb Res 79 (1995) 223-226
18. Ouriel K., Green R.M., DeWeese J.A., and Cimino C. Activated protein C resistance: prevalence and implications in peripheral vascular disease. J Vasc Surg 23 (1996) 46-52
19. Irvine C.D., Foley W.X., Standen G.R., and Morse C. Should patients with atherosclerosis or peripheral vascular disease be stratified for factor V Leiden?. Blood 90 (1997) 2114
20. Sampram E.S., and Lindblad B. The impact of factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions. Eur J Vasc Endovasc Surg 22 (2001) 134-138
21. Fox C.S., Larsomn M.G., Corey D., et al. Absence of association between polymorphisms in the hemostatic factor pathway genes and carotid intimal medial thickness: the Framingham Heart Study. Stroke 35 (2004) e65-e67
22. Luc G., Bard J.M., Arveiler D., et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: the ECTIM study. Arterioscler Thromb 14 (1994) 1412-1419
23. Couderc R., Mahieux F., Bailleul S., Fenelon G., Mary R., and Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. Stroke 24 (1993) 661-664
24. Karvonen J., Kauma H., Kervinen K., et al. Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men. J Hypertens 20 (2002) 2371-2378
25. Xiang G.D., Hu T.H., and Wang Y.L. Apolipoprotein E genotypes and carotid artery atherosclerosis in type 2 diabetes mellitus. Chung Hua Hsueh Chuan Hsueh Tsa Chih 20 (2003) 66-68
26. Tada H. The E4 allele of apolipoprotein E is associated with increased restenosis after coronary angioplasty. Tokai J Exp Clin Med 26 (2001) 81-89
27. Koch W., Mehilli J., Pfeufer A., Schomig A., and Kastrati A. Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting. J Lipid Res 45 (2004) 2221-2226